Psychiatry Research: Neuroimaging
Volume 163, Issue 3 , Pages 236-247 , 30 August 2008

Functional MRI study of brain activation alterations in patients with obsessive–compulsive disorder after symptom improvement

  • Maiko Nabeyama

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Akiko Nakagawa

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • Department of Psychiatry, Kawasaki Medical School, Okayama, Japan
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, Japan. Tel.: +81 86 462 1111; fax: +81 86 464 1193.
    • ,
  • Takashi Yoshiura

      Affiliations

    • Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Tomohiro Nakao

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Eriko Nakatani

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Osamu Togao

      Affiliations

    • Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Chika Yoshizato

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Kazuko Yoshioka

      Affiliations

    • Clinical Psychology and Community Studies, Graduate School of Human Environment Studies, Kyushu University, Fukuoka, Japan
    • ,
  • Mayumi Tomita

      Affiliations

    • Clinical Psychology and Community Studies, Graduate School of Human Environment Studies, Kyushu University, Fukuoka, Japan
    • ,
  • Shigenobu Kanba

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Received 26 January 2007 ,Revised 22 September 2007 ,Accepted 6 November 2007.

References 

  1. Allen G, Buxton RB, Wong EC, Courchesne E. Attentional activation of the cerebellum independent of motor involvement. Science. 1997;275:1940–1943
  2. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:9985–9990
  3. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM. Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Research. 2002;110:165–174
  4. Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive–compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry. 1987;44:211–218
  5. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive–compulsive disorder. Archives of General Psychiatry. 1992;49:681–689
  6. Baxter LR, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive–compulsive disorder. American Journal of Psychiatry. 1988;145:1560–1563
  7. Bench CJ, Frith CD, Grasby PM, Friston KJ, Paulesu E, Frackowiak RS, et al. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia. 1993;31:907–922
  8. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates in obsessive–compulsive disorder. Patients treated with clomipramine. Archives of General Psychiatry. 1990;47:840–848
  9. Botvinick M, Nystrom LE, Fissell K, Carter CS, Cohen JD. Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature. 1999;402:179–181
  10. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research: Neuroimaging. 1998;84:1–6
  11. Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, et al. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive–compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Research: Neuroimaging. 2000;99:15–27
  12. Carter CS, Mintun M, Cohen JD. Interference and facilitation effects during selective attention: an H215O PET study of Stroop task performance. NeuroImage. 1995;2:264–272
  13. Christensen KJ, Kim SW, Dysken MW, Hoover KM. Neuropsychological performance in obsessive–compulsive disorder. Biological Psychiatry. 1992;31:4–18
  14. Clayton IC, Richards JC, Edwards CJ. Selective attention in obsessive–compulsive disorder. Journal of Abnormal Psychology. 1999;108:171–175
  15. Corbetta M, Shulman GL, Miezin FM, Peterson SE. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science. 1995;270:802–805
  16. Courchesne E, Townsend J, Akshoomoff NA, Saitoh O, Yeung-Courchesne R, Lincoln AJ, et al. Impairment in shifting attention in autistic and cerebellar patients. Behavioral Neuroscience. 1994;108:848–865
  17. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry. 1976;33:766–771
  18. Enright SJ, Beech AR. Obsessional states: anxiety disorders or schizotypes? An information processing and personality assessment. Psychological Medicine. 1990;20:621–627
  19. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders. Patient Edition. New York: New York State Psychiatric Institute; 1996;
  20. Gehring WJ, Himle J, Nisenson LG. Action-monitoring dysfunction in obsessive–compulsive disorder. Psychological Science in the Public Interest. 2000;11:1–6
  21. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale–Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry. 1989;46:1012–1016
  22. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 1989;46:1006–1011
  23. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32:50–55
  24. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62
  25. Hodgson RJ, Rachman S. Obsessive–compulsive complaints. Behaviour Research and Therapy. 1977;15:389–395
  26. Iikura Y. Treatment Guide for Obsessive–Compulsive Disorder. Osaka: Nihei-Sha; 1999;
  27. Jentsch JD, Taylor JR. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology. 2001;24:66–74
  28. Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive–compulsive disorder. Acta Psychiatrica Scandinavica. 2003;107:291–297
  29. Kato M. A study on the concept formation and shift of the patients with frontal lesions—a neuropsychological investigation by the New Modified Wisconsin Card Sorting Test-. Keio Igaku. 1988;65(6):861–885
  30. Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS. Anterior cingulate conflict monitoring and adjustments in control. Science. 2004;303:1023–1026
  31. Kim SG, Ugurbil K, Strick PL. Activation of a cerebellar output nucleus during cognitive processing. Science. 1994;265:949–951
  32. Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive–compulsive disorder: a critical review. Biological Psychology. 2004;65:185–236
  33. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:5675–5679
  34. Le TH, Pardo JV, Hu X. 4T-fMRI study of nonspatial shifting of selective attention: cerebellar and parietal contributions. The American Psysiological Society. 1998;1535–1548
  35. MacDonald AW, Cohen JD, Stenger VA, Carter CS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science. 2000;288:1835–1838
  36. Machlin SR, Harris GJ, Pearlson GD, Hoehn-Saric R, Jeffery P, Camargo EE. Elevated medial-frontal cerebral blood flow in obsessive–compulsive patients: a SPECT study. American Journal of Psychiatry. 1991;148:1240–1242
  37. Martinot JL, Allilaire JF, Mazoyer BM, Hantouche E, Huret JD, Legaut-Demare F, et al. Obsessive–compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta Psychiatrica Scandinavica. 1990;82:233–242
  38. Milham MP, Banich MT, Claus ED, Cohen NJ. Practice-related effects demonstrate complementary roles of anterior cingulate and prefrontal cortices in attentional control. NeuroImage. 2003;18:483–493
  39. Moritz S, Birkner C, Kloss M, Jahn H, Hand I, Haasen C, et al. Executive functioning in obsessive–compulsive disorder, unipolar depression, and schizophrenia. Archives of Clinical Neuropsychology. 2002;17:477–483
  40. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al. A functional MRI comparison of patients with obsessive–compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Research: Neuroimaging. 2005;139:101–114
  41. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al. Brain activation of patients with obsessive–compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biological Psychiatry. 2005;57:901–910
  42. Nakatani E, Nakagawa A, Nakao T, Yoshizato C, Nabeyama M, Kudo A, et al. A randomized controlled trial of Japanese patients with obsessive–compulsive disorder-effectiveness of behavior therapy and fluvoxamine. Psychotherapy and Psychosomatics. 2005;74:269–276
  43. Nakatani E, Nakgawa A, Ohara Y, Goto S, Uozumi N, Iwakiri M, et al. Effects of behavior therapy on regional cerebral blood flow in obsessive–compulsive disorder. Psychiatry Research: Neuroimaging. 2003;124:113–120
  44. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology. 1989;2:23–28
  45. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97–113
  46. Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:256–259
  47. Penades R, Catalan R, Andres S, Salamero M, Gasto C. Executive function and nonverbal memory in obsessive–compulsive disorder. Psychiatry Research. 2005;133:81–90
  48. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [18F]FDG PET study in obsessive–compulsive disorder: a clinical/metabolic correlation study after treatment. British Journal of Psychiatry,. 1995;166:244–250
  49. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, et al. Mapping structural brain alterations in obsessive–compulsive disorder. Archives of General Psychiatry. 2004;61:720–730
  50. Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive–compulsive disorder before and during treatment. Biological Psychiatry. 1995;38:429–437
  51. Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I. Regional 133xenon cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive–compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Archives of General Psychiatry. 1992;49:695–702
  52. Savage CR, Baer L, Keuthen NJ, Brown HD, Rauch SL, Jenike MA. Organizational strategies mediate nonverbal memory impairment in obsessive–compulsive disorder. Biological Psychiatry. 1999;45:905–916
  53. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive–compulsive disorder vs major depression. Archives of General Psychiatry. 2002;59:250–261
  54. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive–compulsive disorder. Neuropsychopharmacology. 1999;21:683–693
  55. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive–compulsive disorder. British Journal of Psychiatry. 1998;173:26–37
  56. Schmahmann JD, Pandya DN. Anatomical investigation of projections to the basis pontis from posterior parietal association cortices in rhesus monkey. The Journal of Comparative Neurology. 1989;289:53–73
  57. Schmahmann JD, Pandya DN. Prelunate, occipitotemporal, and parahippocampal projections to the basis pontis in rhesus monkey. The Journal of Comparative Neurology. 1993;337:94–112
  58. Schmahmann JD, Pandya DN. Prefrontal cortex projections to the basilar pons in rhesus monkey: implications for the cerebellar contribution to higher function. Neuroscience Letters. 1995;199:175–178
  59. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–579
  60. Schmidtke K, Schorb A, Winkelmann G, Hohagen F. Cognitive frontal lobe dysfunction in obsessive–compulsive disorder. Biological Psychiatry. 1998;43:666–673
  61. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive–compulsive disorder. Archives of General Psychiatry. 1996;53:109–113
  62. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, California, USA: Consulting Psychologists Press; 1970;
  63. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R. Patient edition (SCID-P). Washington, DC: American Psychiatric Press; 1990;
  64. Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology. 1935;18:643–662
  65. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, et al. Cerebral glucose metabolism in childhood-onset obsessive–compulsive disorder. Revisualization during pharmacotherapy. Archives of General Psychiatry. 1992;49:690–694
  66. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, et al. Cerebral glucose metabolism in childhood-onset obsessive–compulsive disorder. Archives of General Psychiatry. 1989;46:518–523
  67. Taylor SF, Kornblum S, Lauber EJ, Minoshima S, Koeppe RA. Isolation of specific interference processing in the Stroop task: PET activation studies. NeuroImage. 1997;6:81–92
  68. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive–compulsive disorder, panic disorder, and hypochondriasis. Archives of General Psychiatry. 2005;62:922–933
  69. Vilensky JA, van Hoesen GW. Corticopontine projections from the cingulate cortex in the rhesus monkey. Brain Research. 1981;205:391–395
  70. Wechsler D. Manual: Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981;
  71. Zysset S, Muller K, Lohmann G, von Cramon DY. Color-word matching Stroop task: separating interference and response conflict. NeuroImage. 2001;13:29–36

PII: S0925-4927(07)00227-2

doi: 10.1016/j.pscychresns.2007.11.001

Psychiatry Research: Neuroimaging
Volume 163, Issue 3 , Pages 236-247 , 30 August 2008

Article Tools

* Image Usage & Resolution